Together to outsmart prostate cancer
September 11, 2024 – The Cancer Research Society (CRS) is proud to announce its strategic partnership with PROCURE, an organization dedicated to the fight against prostate cancer. Together, our two organizations are combining forces to support innovative translational research related to the prevention, detection, or treatment of prostate cancer.
A $2 million investment for scientific breakthroughs
As part of this alliance, $2 million will be allocated to four groundbreaking research projects, each receiving $500,000 over three years. This financial support underscores the unwavering commitment of the CRS and PROCURE to advancing cutting-edge research aimed at improving outcomes and quality of life for men affected by this type of cancer.
“This unique partnership with PROCURE strengthens our support for research on prostate cancer, one of the most common cancers among men in Canada. Together, we have the opportunity to advance knowledge and treatments, offering patients renewed hope.” – Manon Pepin, President and CEO of the CRS.
“We are deeply committed to forming partnerships with various collaborators to advance science. Our collaboration with the Cancer Research Society adds to this valuable list of partners and represents a major step forward in our mission. Together, we aim to push the boundaries of innovation and provide a better future for patients facing prostate cancer.” – Laurent Proulx, President and CEO of PROCURE.
Toward a future where research makes a difference
Through major strategic collaborations, such as this one with PROCURE, the CRS is solidifying its position as a leader in cancer research funding. Every contribution thus becomes a critical lever for advancing research and delivering innovative solutions against cancer.
Cancer Research Society
Founded in 1945, the Cancer Research Society (CRS) is one of the only Canadian organizations exclusively dedicated to research into all types of cancer. Since its inception, the CRS has supported thousands of researchers who have made significant advances in the prevention, detection and treatment of cancer. To date, thanks to the generosity of partners and donors across Canada, the CRS has distributed over $388 million in research grants and scholarships.
PROCURE
PROCURE is a charitable organization in the fight against prostate cancer. It educates, supports, and informs people affected by this disease. It promotes and contributes to the financing of world-class research.